Navigation Links
New Treatment Rivals Chemotherapy For Lymphoma, Study Finds

icular non-Hodgkin's lymphoma after other treatments have failed. The newly published research involves Bexxar as a first-line treatment for this disease.

Non-Hodgkin's lymphoma, the nation's sixth leading cause of cancer death, is a cancer of the lymph system, which is part of the immune system. Lymphoma spreads easily through the lymph system and the bloodstream and consequently tends to be widespread when it is diagnosed. Traditional treatment often involves intensive chemotherapy, or a combination of chemotherapy and the monoclonal antibody rituximab. These treatments are usually given every three weeks over a span of up to six months and can cause many unpleasant side effects, including nausea, hair loss and infections.

Follicular lymphoma is the second most common type of non-Hodgkin's lymphoma and is not considered to be curable using these traditional treatments; even after patients initially have a response to treatment, the disease almost always comes back and becomes more difficult to treat.

Bexxar, whose chemical name is tositumomab and iodine I 131 tositumomab, combines an antibody that seeks out cancer cells, and a radioactive form of the element iodine. When injected, it travels like a guided missile through the bloodstream to bind to a protein found on the surface of the cancerous cells. The radiation zaps these malignant cells with minimal exposure to normal tissues.

With the Bexxar therapeutic regimen, a patient receives an injected test dose of radioactive Bexxar to determine how that patient's body processes the tagged antibody. Nuclear medicine scans are used to assess how quickly Bexxar reaches the tumor and how quickly the radiation disappears from the patient's body. One to two weeks after that initial dose, the patient then receives a custom-tailored therapeutic dose, and therapy is considered complete. The most common side effect is a temporary lowering of blood counts several weeks after the treatment. There
'"/>

Source:University Of Michigan Health System


Page: 1 2 3

Related biology news :

1. Discovery Could Lead To Novel Approaches In HIV Treatment
2. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
3. Effective Cancer Treatments Follow The Clock
4. Protein Discovery Could Unlock The Secret To Better TB Treatment
5. Natural Killers Could Lead to New Hepatitis Treatments
6. FDA Approves New Treatment for Chronic Hepatitis B
7. Study Finds Moderate Hypothermia A Safe Treatment For Traumatic Brain Injury In Kids
8. Drug Offers Alternative to Surgical Treatment After Miscarriage
9. Treatments have same target, different responses for lung cancer patients with genetic mutation
10. Minimally Invasive Cancer Treatments Highlighted
11. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Treatment Rivals Chemotherapy For Lymphoma Study Finds

(Date:6/17/2015)... , June 17, 2015  Crossmatch™, a leading ... that its U.are.U ® 4500 fingerprint readers ... Eateries, Inc., a San Jose, ... to increase security, improve accountability and reduce fraud ... instant, non-repudiable identity confirmation for employee sign in ...
(Date:6/16/2015)... Fingerprint Cards has received an order ... company,s portfolio from one of its module partners in ... place during the third quarter 2015. The sensors will be ... Jörgen Lantto, CEO of FPC, comments: " This ... interest from smartphone OEMs in integrating touch fingerprint sensors in ...
(Date:6/15/2015)... A new report [ 1 ] ... consumers using mobile banking applications want their mobile devices to ... instead of having to prove who they are with passwords ...   -   The Fusion of Financial Services, Mobile and ... channel used by Gen X and Gen Y to access ...
Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4
... Tide" event that occurred off the coast of El ... some 200 sea turtles, according to test results released ... organizations. , Responding to requests from the Salvadoran government ... WCS veterinary pathologist Dr. Julie White journeyed to the ...
... McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins have ... what many have termed "junk" DNA and identified regions ... that these control regions from different species don't have ... will be published online at Science Express March 23. ...
... at the McKusick-Nathans Institute of Genetic Medicine at Johns ... of analyzing what many have termed "junk" DNA and ... have found that these control regions from different species ... The study will be published online at Science Express ...
Cached Biology News:Red Tide causes sea turtle die-off in El Salvador 2Infused spleen cells found not to impact islet recovery and reversal of type 1 diabetes in mice 2Infused spleen cells found not to impact islet recovery and reversal of type 1 diabetes in mice 3Junk DNA may not be so junky after all 2Junk DNA may not be so junky after all 3
(Date:7/7/2015)... ... , ... CSM, a leading clinical trial supply company, today announced that Michael ... extensive background in financial management and accounting, bringing over 20 years of experience in ... will oversee all financial areas of the company to both strengthen CSM’s financial strategy ...
(Date:7/6/2015)... and CARDIFF, UK (PRWEB) , ... July 06, ... ... ophthalmology and other medical fields holds potential to reveal how blood flows in ... reduce stroke-induced damage to the brain. , A new article published in the ...
(Date:7/6/2015)... , July 6, 2015  Approximately 1% of ... integrated into their chromosomes. These individuals are three times ... study published in one of the nation,s leading medical ... Medicine in Canada.  Photo - http://photos.prnewswire.com/prnh/20150706/230685 ... herpesvirus 6 (HHV-6) causes roseola (also known as "sixth ...
(Date:7/6/2015)... DUBLIN , June 29, 2015 ... ) has announced the addition of the ... offering. Biotechnology for the Non-Biotechnologist, ideal ... basic theory, principles, techniques and potential of biotechnology. ... to understand the basic theory, principles, techniques, and ...
Breaking Biology Technology:CSM Appoints Michael Morse as Vice President of Finance 2Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 2Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 3Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 2Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 3
... Pioneer in High Throughput SNP Discovery Brings ... Oct. 14 BioNanomatrix, Inc., a developer,of ... and biomedical research, today announced the appointment ... Ph.D., to its Scientific,Advisory Board (SAB). Dr. ...
... offers unique opportunities to advance the life sciences ... biological materials with unprecedented resolution. The ability to ... of genomics, proteomics and cell adhesion, and may ... screening and disease detection, even when sample volumes ...
... of Late Stent Thrombosis Reported in CUSTOM I, II, and III ... ... PARK, Calif., Oct. 13 ,XTENT, Inc. (Nasdaq: XTNT ) today announced ... that reinforces the,efficacy of the Custom NX(R) drug eluting stent (DES) system ...
Cached Biology Technology:BioNanomatrix Announces Appointment of Dr. Pui-Yan Kwok to Its Scientific Advisory Board 2Researchers write protein nanoarrays using a fountain pen and electric fields 2Researchers write protein nanoarrays using a fountain pen and electric fields 3Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years 2Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years 3
... Cell Identification Kit. ALDEFLUORs ... substrate for the enzyme ... is highly expressed in ... making ALDH an extremely ...
... System is the cost-effective solution for entry ... to common research imaging tasks, MetaVue enables ... simple image analysis. Compatibility with MetaMorphs ... that MetaVue has the power to drive ...
Sterile, Cell culture tested...
... many modifications to the original formulas in efforts ... play an important role in tissue,culture. A salt ... osmotic balance in the medium and to provide ... is as valuable today as when it was ...
Biology Products: